Bausch & Lomb Corp

BLCO: XNYS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
$37.00PgghgfPdqdrws

Bausch & Lomb: Interested Buyers Prepare Bids as Potential Sale Work Underway

The Financial Times reported on Sept. 18 that a number of private equity firms, including Blackstone, Advent International, and TPG, are considering offers for Bausch & Lomb. While there is no guarantee that the firm will be sold off, this increasingly looks to be a more likely option than a spinoff, given that Bausch Health—Bausch & Lomb’s parent company, which owns about 88% of its subsidiary—could use the proceeds to pay down its USD 21.2 billion in long-term debt.

Sponsor Center